Published: Dec 25, 2021
On Thursday, the Food and Drug Administration made what may be the most momentous drug-approval decision in its history: It granted emergency-use authorization for Mercks molnupiravir to treat covid-19. This approval is significant not because molnupiravir is an especially good drug, but because it is a rather ineffective and dangerous one. In particular, molnupiravir might create new variants of SARS-CoV-2 that evade immunity and prolong the pandemic.
Published: May 12, 2019
Unregistered medical cannabis users have been urged to urgently declare cannabinoid medicines in their possession and register as a medical cannabis-users with the Food and Drug Administration (FDA) before the May 21 deadline.